Cerebrospinal Fluid Biomarker Signature in Alzheimer’s Disease Neuroimaging Initiative Subjects

OBJECTIVE: Develop a cerebrospinal fluid biomarker signature for mild Alzheimer’s disease (AD) in Alzheimer’s Disease Neuroimaging Initiative (ADNI) subjects. METHODS: Amyloid-β 1 to 42 peptide (Aβ(1-42)), total tau (t-tau), and tau phosphorylated at the threonine 181 were measured in (1) cerebrospi...

詳細記述

保存先:
書誌詳細
主要な著者: Shaw, Leslie M., Vanderstichele, Hugo, Knapik-Czajka, Malgorzata, Clark, Christopher M., Aisen, Paul S., Petersen, Ronald C., Blennow, Kaj, Soares, Holly, Simon, Adam, Lewczuk, Piotr, Dean, Robert, Siemers, Eric, Potter, William, Lee, Virginia M.-Y., Trojanowski, John Q.
フォーマット: Artigo
言語:Inglês
出版事項: 2009
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2696350/
https://ncbi.nlm.nih.gov/pubmed/19296504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21610
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料